Cadila Healthcare Ltd (CADILAHC) - Financial and Strategic SWOT Analysis Review

Region:Asia

Author(s):

Product Code:GDPH34377FSA

Download Sample Report download
Buy the Full ReportStarting from $125
Published on

July 2019

Total pages

56

Table of Content

Download Sample Report download
Buy the Full ReportStarting from $125

About the Report

About the Report

Cadila Healthcare Ltd (CADILAHC)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Cadila Healthcare Ltd (Zydus Cadila) is an integrated global healthcare provider. It discovers, develops, manufactures and markets various healthcare products. The company's product portfolio includes active pharmaceutical ingredients (APIs), formulations, wellness and animal health products. Zydus Cadila's products find application in the treatment of diseases in the therapeutic areas of gastrointestinal, cardiovascular, respiratory, pain management, cancer, inflammation, neurology, and women's health, among others. It conducts research to develop biologics, vaccines and new chemical entities. The company has manufacturing facilities in Brazil and India. It has presence in the US, Europe, South Africa, Japan, Brazil, and other emerging markets. Zydus Cadila is headquartered in Ahmedabad, Gujarat, India.

Cadila Healthcare Ltd Key Recent Developments

Jun 17,2019: Cadila Healthcare formulations manufacturing facility located at SEZ Ahmedabad has received an Establishment Inspection Report (EIR)

Jun 15,2019: Manufacturing facility of Alidac Pharmaceuticals Limited, 100% subsidiary of Cadila Healthcare Limited received an Establishment Inspection Report (EIR)

Jun 03,2019: Cadila Healthcare announces USFDA inspection of the Company's manufacturing facilities located at St. Louis, MO, USA

May 29,2019: Zydus Cadila's total income from operations up by 15% in Q4

Apr 30,2019: Zydus and SIFI from Italy announce marketing alliance to launch Innovative Intraocular Lenses in India

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Products

Products

Cadila Healthcare Ltd, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Sun Pharmaceutical Industries Ltd

Piramal Enterprises Ltd

Cipla Ltd

Lupin Ltd

Gufic BioSciences Ltd

IPCA Laboratories Ltd

Dr. Reddy's Laboratories Ltd

Table of Contents

Table of Contents

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Cadila Healthcare Ltd-Key Facts

Cadila Healthcare Ltd-Key Employees

Cadila Healthcare Ltd-Key Employee Biographies

Cadila Healthcare Ltd-Major Products and Services

Cadila Healthcare Ltd-History

Cadila Healthcare Ltd-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Joint Venture

Section 2-Company Analysis

Company Overview

Cadila Healthcare Ltd-Business Description

Product Category: Alliances

Performance

Product Category: Animal Health

Overview

Performance

Product Category: API

Overview

Performance

Product Category: Formulations

Overview

Performance

Product Category: Others

Performance

Product Category: Wellness

Overview

Performance

R&D Overview

Cadila Healthcare Ltd-Corporate Strategy

Cadila Healthcare Ltd-SWOT Analysis

SWOT Analysis-Overview

Cadila Healthcare Ltd-Strengths

Cadila Healthcare Ltd-Weaknesses

Cadila Healthcare Ltd-Opportunities

Cadila Healthcare Ltd-Threats

Cadila Healthcare Ltd-Key Competitors

Section 3-Company Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Company's Lifesciences Financial Deals and Alliances

Cadila Healthcare Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Cadila Healthcare Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Cadila Healthcare Ltd, Recent Deals Summary

Section 5-Company's Recent Developments

Jun 17, 2019: Cadila Healthcare formulations manufacturing facility located at SEZ Ahmedabad has received an Establishment Inspection Report (EIR)

Jun 15, 2019: Manufacturing facility of Alidac Pharmaceuticals Limited, 100% subsidiary of Cadila Healthcare Limited received an Establishment Inspection Report (EIR)

Jun 03, 2019: Cadila Healthcare announces USFDA inspection of the Company's manufacturing facilities located at St. Louis, MO, USA

May 29, 2019: Zydus Cadila's total income from operations up by 15% in Q4

Apr 30, 2019: Zydus and SIFI from Italy announce marketing alliance to launch Innovative Intraocular Lenses in India

Apr 03, 2019: Zydus Cadila: USFDA inspection at the SEZ plant

Nov 02, 2018: Zydus Wellness reports 2nd quarter ended September 30, 2018 financial results

Oct 16, 2018: Zydus Cadila Receives EIR from FDA for its Biologics Manufacturing Facility in Ahmedabad

Oct 04, 2018: Cadila Healthcare's manufacturing facility Zydus Biologics receives an Establishment Inspection Report from USFDA

Sep 26, 2018: Liva Pharmaceuticals Completes FDA Inspection for its Injectables Manufacturing Facility in Vadodara, India

Section 6-Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List of Figure

List of Figures

Cadila Healthcare Ltd, Performance Chart (2015-2019)

Cadila Healthcare Ltd, Ratio Charts

Cadila Healthcare Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Cadila Healthcare Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List of Table

List of Tables

Cadila Healthcare Ltd, Key Facts

Cadila Healthcare Ltd, Key Employees

Cadila Healthcare Ltd, Key Employee Biographies

Cadila Healthcare Ltd, Major Products and Services

Cadila Healthcare Ltd, History

Cadila Healthcare Ltd, Other Locations

Cadila Healthcare Ltd, Subsidiaries

Cadila Healthcare Ltd, Joint Venture

Cadila Healthcare Ltd, Key Competitors

Cadila Healthcare Ltd, Ratios based on current share price

Cadila Healthcare Ltd, Annual Ratios

Cadila Healthcare Ltd, Annual Ratios (Cont...1)

Cadila Healthcare Ltd, Annual Ratios (Cont...2)

Cadila Healthcare Ltd, Interim Ratios

Cadila Healthcare Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Cadila Healthcare Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Cadila Healthcare Ltd, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

You can also purchase parts of this report.
Do you want to check out a section wise price list?
Get Price Break-up

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022